According to the Report of 19th National Congress of the Communist Party of China, Implement the “Healthy China” Strategy, to make people’s health an important symbol of national prosperity and prosperous, combining the national strategies of the Guangdong-HongKong-Macau Greater Bay Area urban agglomeration, Hybribio Co., Ltd , Chinese Maternal And Child Health Association, and Federation of Hongkong Chiu Chou Community Organization, Guangdong Maternal and Child Health Association, jointly organized — The Greater Bay Area (Guangzhou.Hongkong) Healthy Medical Industry Seminar successfully on January 5-6, 2018 at the Hybribio Biology Park, Sino-Singapore Guangzhou Knowledge City, Guangzhou, China.
The Seminar was of great significance to carry out innovation and development of biomedical industry and explore the development of medicine and medical integration of Guangdong, Hong Kong and Macao. Under the “Healthy China” strategy and other national policies, Guangdong-Hong Kong-Macau Greater Bay Area has a great place in the health industry and has great development space and platform, with its own advantages of location, industry and system.
Mr. Chen Ziquan, president of China Maternal and Child Health Association; Academician Zheng Yaozong, former president University of Hong Kong; Dr. Chen Younan, president of Hongkong Chiu Chow Chamber of Commerce, Federation of Hongkong Chiu Chou Community Organization; Dr. Yang Zizhi, former vice president and the Dean of Medicine of the University of Hong Kong, present professor of surgery and M.D of University of Hong Kong; Mr. Zeng Guanghui, vice-chairman of Chinese Maternal and Child Health Association; Professor Li Xiaochuan, director of Medical Physics of Department of Radiation oncology of Medical College of Wisconsin; Professor Wang Qingtao, Beijing clinical testing center, and other experts were invited to make an in-depth exploration around these subjects of Spirit of the 19th National Congress of the Communist Party of China, Massive Health Industry, Cooperation among 9+2 cities and regions of Greater Bay Area. The purpose of this seminar is to integrate the advantages of technologies, capitals and markets in the area of Guangdong, Hong Kong and Macao, enhance the cooperation in the fields of Medical Industry and Medical service, promote the development of Greater Bay Area among Governments, enterprises and colleges under the strategy of the Belt and Road, make Greater Bay Area a good example in the development of Health China and innovation and development of National Massive Health Industry.
These experts from Guangdong and Hongkong made the speaches with the subjects of Polices and Prospects of Guangdong and Hongkong Healthy and Medical Industry cooperation, Integrate and Make good use of Hongkong Medical Technologies and Qualifications, New Era New Market New Chance, Medical Resources Integration between Hongkong and Mainland, Current Situation and Opportunity of Privately-Owned Image Tumor Center, Development Tendency of Image Medical Diagnosis and The Technology of Molecular Diagnostics and Medical in the 21st Century.
Hybribio Hongkong-Guangzhou Joint Laboratory
Demonstration Base of Birth Defects Control Deafness Genes Detection
Production and Research Base of Guangdong Food and Drug Vocational College
Enterprise workstation of Academician and Experts of Guangdong Province
As the domestic enterprise of Molecular Diagnostics, Hybribio has made a successful industrialization path, as a good example of Guangdong-Hongkong Cooperation. In the Year of 2016, Hybribio’s innovation patents of Human Papilloma Virus Genoarray Kits and Gene-chip Preparation Method was awarded the Golden Prize of the 18th China Invention Patent Award, successfully listed in Shenzhen Gem in April 12th, 2017. During the Seminar, the President of Hybribio, Mr Kun shared the experience of industrialization, the Gm Ms. WANG talked about How to make Hybribio as the pioneer of the Massive Healthy Industries with the new thought in the new era. The nameplates of Hybribio Hongkong-Guangzhou Joint Laboratory, Demonstration Base of Birth Defects Control Deafness Genes Detection, Production and Research Base of Guangdong Food and Drug Vocational College, Enterprise workstation of Academician and Experts of Guangdong Province were unveiled.
As the great diagnostic partner of clinical experts, Hybribio has layouted the network of the third party molecular clinical labs. Hybribio’s Hongkong Molecular Pathology Detection Center has started to provide the services since 2012, as the first Cancer Gene Detection Center of Hongkong, providing precious experience for the domestic third party clinical labs set-up. Hybribio has established 20 labs in Guangzhou, Beijing, Shanghai and other cities, covering the national molecular detection network.
Hybribio will insist in conscientious quality and scientific management, assist the development of Chinese Health Industry. With the advantages of years of brand and the strength of innovative development, management, capital advantage, Hybribio will make new mode of Massive Health in the shared regions, make the new future of the development of health Industry in Greater Bay Area.